Navigation Links
Drug May Make Breathing Easier for Millions ,,

An experimental drug could make millions of people suffering from smoker’s lung breathe much easier.

Chronic Obstructive Pulmonary Disease (COPD) or smoker’s lung, is an irreversible progressive illness caused by narrowing of the airways. It encompasses emphysema and chronic bronchitis. In tests involving 500 people who had suffered from COPD for more than a decade, the drug appeared to be safer and better at improving breathing and at reducing infections and hospital visits than the best current treatment, researchers said. They were addressing scientists at the World Congress on Lung Health recently.

The inhaled drug, Spiriva, could be available by the year 2002. And if it turns out to be as good as it looks right now, it could improve the quality of life for nearly half of the 600 million people with the disease, said Dr. Bartolome Celli. Celli is chief of pulmonary and critical care at St. Elizabeth’s Hospital in Boston.

While the drug may not slow the deterioration of the lungs, many sufferers could see their overall well-being improve by between 30 and 50 percent, said Celi.
'"/>




Page: 1

Related medicine news :

1. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
2. Fear Of Flying Can Be Overcome By Deep Breathing
3. Sleep Apnea Patients Benefit from Breathing Mask
4. Breathing Exercises A Boon To Asthma Patients
5. Asthma Could be Combated by Breathing Exercises
6. Breathing Exercises Scores Over Inhalers
7. Sensitive Test Developed To Detect Breathing Problems In Very Young Children
8. Prevalence of Self-reported Snoring, Sleep-disordered Breathing in Military
9. Sleep-related Breathing Disorder could Indicate Depression
10. Breathing Exercises help cardiac patients to breeze through surgery
11. Babies with Breathing Troubles at Birth may get Asthma
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
Breaking Medicine Technology: